| Brimonidine in Rosacea (NCT05401422) | Cairo University | 2022-05-25 |
| Evaluation of the Safety and Efficacy of Topical Roflumilast Cream in the Treatment of Facial Papulopustular Rosacea (NCT05278624) | Dermatology Consulting Services, PLLC | 2022-04-15 |
| Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea (NCT06282679) | Nanjing First Hospital, Nanjing Medical University | 2022-04-01 |
| A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants (NCT05094700) | Johnson & Johnson Consumer Inc. (J&JCI) | 2021-10-25 |
| Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea (NCT05045469) | Chang Gung Memorial Hospital | 2021-08-04 |
| Clinical Benefit of M89PB in Subjects With Rosacea Associated With Erythema and Sensitive Skin (NCT04898582) | Institute of Skin and Product Evaluation, Italy | 2021-05-18 |
| CGB-400 Topical Gel for the Treatment of Inflammatory Lesions of Rosacea (NCT04886739) | CAGE Bio Inc. | 2021-05-07 |
| Rosacea and Ivermectin (NCT04275999) | Wake Forest University Health Sciences | 2021-04-16 |
| M89PF in Rosacea Associated With Erythema and Sensitive Skin (NCT05562661) | Cosmetique Active International | 2021-01-02 |
| Analysis of the Microbiome in Rosacea (NCT04108897) | Johns Hopkins University | 2019-09-17 |
| Role of the Sympathetic Nervous System in Rosacea (NCT03989492) | Kristen Metzler-Wilson | 2019-05-24 |
| A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream" (NCT03954444) | Actavis Inc. | 2019-04-15 |
| 4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness (NCT03841032) | Bayer | 2019-01-28 |
| Intense Pulsed Light as an Adjunctive to Bromonidine for the Treatment of Rosacea (NCT03053700) | Rabin Medical Center | 2018-12-01 |
| PACAP38 Induced Headache and Rosacea-like Symptoms in Patients With Rosacea (NCT03878784) | Danish Headache Center | 2018-11-12 |
| CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes (NCT04508205) | CAGE Bio Inc. | 2018-10-26 |
| CGB-400 for the Reduction of Facial Redness (NCT04508660) | CAGE Bio Inc. | 2018-10-26 |
| Deep Phenotyping of Rosacea and Migraine (NCT03872050) | Danish Headache Center | 2018-09-14 |
| A Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Rosacea (NCT03590366) | AOBiome LLC | 2018-07-02 |
| The Suitability of Two Skin Care Regimens in Moderate to Severe Facial Rosacea (NCT03392558) | Burt's Bees Inc. | 2018-01-01 |
| To Evaluate the Therapeutic Equivalence and Safety in Treatment of Moderate Facial Rosacea (NCT03689010) | Sun Pharmaceutical Industries, Inc. | 2017-12-12 |
| Safety and Tolerability of Oxymetazoline and Energy-Based Therapy in Participants With Rosacea (NCT03380390) | Aclaris Therapeutics, Inc. | 2017-12-04 |
| Evaluation of Cutera Excel V™ Laser With Green Genesis and Micro-Lens Array (MLA)Attachment (NCT03424304) | Cutera Inc. | 2017-11-06 |
| Lipidome and Microbiome Profile of the Eye in Rosacea (NCT03655197) | University of California, Davis | 2017-11-02 |
| Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea (NCT03263273) | Hovione Scientia Limited | 2017-10-30 |
| An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea (NCT03352323) | Padagis LLC | 2017-10-18 |
| A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules (NCT03340961) | Dr. Reddy's Laboratories Limited | 2017-10-01 |
| Treatment of Dilated Blood Vessels on the Cheeks With a New Yellow Laser and a Traditional Green Laser (NCT03472859) | Tampere University Hospital | 2017-10-01 |
| Characterization of the Facial and Gut Microbiome in Rosacea (NCT03228927) | The Acne Cure Alliance | 2017-08-05 |
| A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea (NCT03193372) | LEO Pharma | 2017-07-20 |
| Oracea Soolantra Association in Participants With Severe Rosacea (NCT03075891) | Galderma R&D | 2017-07-05 |
| Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component) (NCT03253666) | Harvard School of Public Health (HSPH) | 2017-01-01 |
| Bioequivalence Study of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea on the Face (NCT02800148) | Padagis LLC | 2016-11-01 |
| EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA (NCT03211585) | Syneron Medical | 2016-10-01 |
| A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea (NCT03287791) | Actavis Inc. | 2016-07-19 |
| To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel (NCT03094403) | Sun Pharmaceutical Industries, Inc. | 2016-07-01 |
| Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation. (NCT02806414) | University of California, San Diego | 2016-07-01 |
| Pharmacokinetics of Doxycycline in Skin of Healthy Volunteers (NCT03478436) | Medical University of Vienna | 2016-07-01 |
| A Study to Assess the Efficacy, Safety and Tolerability of DFD-04 (NCT02828241) | Dr. Reddy's Laboratories Limited | 2016-07-01 |
| Internet Surveys and Their Impact on Adherence for Rosacea (NCT03048058) | Wake Forest University Health Sciences | 2016-05-05 |
| Comparative Safety and Efficacy of Two Treatments in the Treatment of Inflammatory Lesions of Rosacea (NCT02795117) | Padagis LLC | 2016-05-01 |
| Timolol for the Treatment of Acne and Rosacea (NCT02774590) | Johns Hopkins University | 2016-03-01 |
| Genetic Basis of Rosacea Study (Control) (NCT02749786) | Stanford University | 2016-01-21 |
| Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle (NCT02547441) | Maruho Co., Ltd. | 2015-12-01 |
| MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea. (NCT02616250) | Galderma R&D | 2015-12-01 |
| Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE) (NCT02637232) | Galderma R&D | 2015-10-01 |
| Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle (NCT02576860) | Maruho Co., Ltd. | 2015-10-01 |
| Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel (NCT02576847) | Maruho Co., Ltd. | 2015-10-01 |
| Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea (NCT02601963) | Vyne Therapeutics Inc. | 2015-09-01 |
| Demodex Density, Immune Response and Oxidative Stress in Rosacea Patients (NCT02556827) | Istanbul Training and Research Hospital | 2015-07-01 |
| Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea (NCT02385240) | Padagis LLC | 2015-03-01 |
| Preferences & Treatment Satisfaction Drivers in Rosacea Patients (NCT02602470) | LEO Pharma | 2015-01-08 |
| A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea (NCT02583009) | Amorepacific Corporation | 2014-10-01 |
| Mirvaso in Use Study (NCT02249065) | Galderma R&D | 2014-09-01 |
| Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea (NCT02289352) | Actavis Inc. | 2014-07-01 |
| Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea (NCT02132117) | Allergan | 2014-06-01 |
| Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea (NCT02131636) | Allergan | 2014-05-01 |
| Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea (NCT02144181) | Ulthera, Inc | 2014-05-01 |
| A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea (NCT02095158) | Allergan | 2014-04-01 |
| Effect of CD07805/47 Gel in Rosacea Flushing (NCT02300129) | Galderma R&D | 2014-04-01 |
| RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea (NCT02204254) | Centre Hospitalier Universitaire de Nice | 2014-03-01 |
| Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis (NCT02036229) | Rabin Medical Center | 2014-02-01 |
| A Safety and Efficacy Study of DRM02 in Subjects With Rosacea (NCT01993446) | Dermira, Inc. | 2013-10-01 |
| Assessment of the Rosacea Prevalence in the General Population (NCT02292797) | Galderma R&D | 2013-09-01 |
| A Study to Evaluate the Safety and Clinical Study of Azelaic Acid Gel 15% in Patients With Moderate Facial Rosacea (NCT02120924) | Actavis Inc. | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Patient-Reported Outcome Of Facial Erythema (PROOF) (NCT01885000) | Galderma R&D | 2013-07-01 |
| Rifaximin Treatment of Papulopustular Rosacea (NCT01359228) | University of California, San Francisco | 2013-04-01 |
| Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea (NCT01789775) | Galderma R&D | 2012-12-01 |
| AGN-199201 for the Treatment of Erythema With Rosacea (NCT01735201) | Allergan | 2012-12-01 |
| A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea (NCT01740934) | Rock Creek Pharmaceuticals, Inc. | 2012-11-01 |
| Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea (NCT01659853) | Galderma R&D | 2012-09-01 |
| Rosacea Prevalence in General Population - Pilot Study (NCT02292836) | Galderma R&D | 2012-08-01 |
| A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea (NCT01614743) | DeNova Research | 2012-06-01 |
| Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale (NCT01636765) | Allergan | 2012-05-01 |
| Genetic Basis of Rosacea (NCT02787616) | Stanford University | 2012-04-13 |
| Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea (NCT01579084) | Allergan | 2012-04-01 |
| Safety and Efficacy of the Luxe Device to Treat Facial Wrinkles and Rosacea (NCT01618864) | Syneron Medical | 2012-03-01 |
| Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness (NCT01529996) | Northwestern University | 2012-01-01 |
| A Study of DER 45-EV Gel to Treat Rosacea (NCT00940992) | Sol-Gel Technologies, Ltd. | 2012-01-01 |
| A Study of Laropiprant (MK-0524) in Participants With Moderate to Severe Erythematotelangiectatic Rosacea (MK-0524-155) (NCT01451619) | Merck Sharp & Dohme LLC | 2011-11-01 |
| Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo (NCT01426269) | Galderma R&D | 2011-09-01 |
| A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea (NCT01513863) | Sun Pharmaceutical Industries, Inc. | 2011-08-01 |
| Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation (NCT01398280) | University of California, San Diego | 2011-07-01 |
| Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea (NCT01355471) | Galderma R&D | 2011-05-01 |
| Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea (NCT01355458) | Galderma R&D | 2011-05-01 |
| Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo (NCT01308619) | Galderma R&D | 2011-04-01 |
| Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea (NCT01318733) | Galderma R&D | 2011-03-01 |
| Azelaic Acid on Demodex Counts in Rosacea (NCT03035955) | Wake Forest University | 2010-12-01 |
| Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea (NCT01174030) | Galderma R&D | 2010-08-01 |
| Combination Gel and Vascular ND in Mild to Moderate Rosacea (NCT01631656) | Wake Forest University Health Sciences | 2010-07-01 |
| Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients (NCT01134991) | Vyne Therapeutics Inc. | 2010-06-01 |
| Efficacy of Oral Minocycline (Solodyn) and Oral Minocycline (Solodyn) Plus Azelaic Acid (Finacea) for Acne Rosacea (NCT05014906) | Dermatology Specialists Research | 2010-05-01 |
| Atralin Gel for the Treatment of Rosacea (NCT01125930) | Lisa E. Maier | 2010-05-01 |
| The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage (NCT00991198) | Aria Aesthetics Inc. | 2009-09-01 |
| ORCA - Oracea® for Rosacea: A Community-based Assessment (NCT00892281) | Galderma R&D | 2009-04-01 |
| Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea (NCT00823901) | Massachusetts General Hospital | 2009-02-01 |
| Potential Research Study Participant Registry (NCT00710489) | University of California, Davis | 2008-05-01 |
| A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea (NCT00621218) | Coria Laboratories, Ltd. | 2008-02-01 |
| An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1% (NCT00668655) | Galderma R&D | 2008-02-01 |